Beta Bionics, Inc. (BBNX) — Stock Score Summary

Beta Bionics, Inc. (BBNX) has a MoatMap StockRank of 11/100 based on Quality (43/100), Value (40/100), and Momentum (11/100) factor scores. The current signal is STRONG SELL. Beta Bionics is an early-stage medical technology company developing autonomous insulin delivery systems. It is currently unprofitable, capital-intensive, and lacks the established cash flows and pricing power required for our concentrated portfolio.

Beta Bionics, Inc. is a medical technology company focused on transforming diabetes management through its innovative iLet Bionic Pancreas system, an FDA-approved autonomous insulin delivery device. This system aims to simplify glucose control for users by independently adjusting insulin dosages. Its unique algorithm and potential for dual-hormone delivery position it as a significant player in the rapidly advancing automated insulin delivery market.

Key Financial Metrics

Price$14.28
Market Cap$539M
P/E (Forward)-5.81
Price/Book2.28
Return on Equity-22.7%
Return on Invested Capital-24.1%
Debt/Equity2.55
Gross Margin57.2%
Operating Margin-87.9%
Revenue Growth56.6%
Free Cash Flow$-44M

Beta Bionics, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Beta Bionics, Inc.’s (BBNX) StockRank?
MoatMap’s StockRank for Beta Bionics, Inc. (BBNX) is 11/100, with a Strong Sell signal. It is a composite of Quality (43), Value (40), and Momentum (11) factor ranks across MoatMap’s 19,000+ stock universe.
Does Beta Bionics, Inc. have an economic moat?
Beta Bionics, Inc. (BBNX) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beta Bionics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Beta Bionics, Inc. (BBNX) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beta Bionics, Inc. in?
Beta Bionics, Inc. (BBNX) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksBBNX deep dive reportAI ChampionsHow we score stocksSense-check another stock